Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11-vascular-targeted photodynamic (VTP) therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11-vascular-targeted photodynamic (VTP) therapy

Published:2015-04-21 Issue:6 Volume:116 Page:888-896
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Moore Caroline M.¹,Azzouzi Abel-Rahmene²,Barret Eric³,Villers Arnauld⁴,Muir Gordon H.⁵,Barber Neil J.⁶,Bott Simon⁶,Trachtenberg John⁷,Arumainayagam Nimalan¹,Gaillac Bertrand⁸,Allen Clare¹,Schertz Avigdor⁹,Emberton Mark¹

Affiliation:

1. Division of Surgery and Interventional Science; University College London; London UK

2. CHU; Angers France

3. Institut Monsouris; Paris France

4. Hôpital Claude Huriez; CHRU; Lille France

5. King's College Hospital; London UK

6. Frimley Park and Basingstoke Hospitals; Surrey UK

7. Princess Margaret Hospital; Toronto Canada

8. Steba Biotech; Paris France

9. Plant Sciences; Weizmann Institute of Science; Rehovot Israel

Funder

UK National Institute of Health Research

University College London Hospitals

NHS Foundation Trust

University College London

Comprehensive Biomedical Research Centre

Steba Biotech

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.12816/fullpdf

Reference16 articles.

1. Time trends and local variation in primary treatment of localized prostate cancer;Cooperberg;J Clin Oncol,2010

2. Contemporary trends in low risk prostate cancer: risk assessment and treatment;Cooperberg;J Urol,2007

3. Active surveillance for prostate cancer: a review;Klotz;Curr Urol Rep,2010

4. Quality of life outcomes following treatment for localized prostate cancer: is there a clear winner?;Parker;Curr Opin Urol,2009

5. How good Is MRI at detecting and characterising cancer within the prostate?;Kirkham;Eur Urol,2006

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic and Diagnostic Agents based on Bioactive Endogenous and Exogenous Coordination Compounds;Current Medicinal Chemistry;2024-01

2. A Trojan horse approach for efficient drug delivery in photodynamic therapy: focus on taxanes;Journal of Materials Chemistry B;2023

3. Sensitizers in photodynamic therapy;Nanomaterials for Photodynamic Therapy;2023

4. Photodynamic therapy for prostate cancer: Recent advances, challenges and opportunities;Frontiers in Oncology;2022-09-23

5. The combinational application of photodynamic therapy and nanotechnology in skin cancer treatment: A review;Tissue and Cell;2022-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3